Using real world data to provide aftercare plans

Pharmacology update from ONS 2019

Checkpoint inhibitor induced Guillain-Barré syndrome

Long-term safety of niraparib maintenance treatment in patients with recurrent ovarian cancer

Treating ovarian cancers with PARP inhibitors

Managing the side effects of CAR T-cell therapy

Updates in surgical oncology

Evidence-based radiation side effect management

Clinical photography in cancer care

The Brain Tumour Charity

Current treatment for brain tumours

Talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer